Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Rein
- | Specialty :
- Thérapies Ciblées
Extract
A phase II, multi-centre, open-label study to assess the efficacy, safety, tolerability and pharmacokinetics of intrapatient dose escalation of sorafenib as first line treatment for metastatic renal cell carcinoma.
Scientific Abstract
en cours d'intégration;